Summary
Signal counts
Assets tracked: 2
Watchlist assets: 2
Registry stop assets: 0
Sponsor overview
Royal Marsden NHS Foundation Trust
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT04242459 | https://clinicaltrials.gov/study/NCT02771353
Assets
Linked programs
- Adaptive Radiotherapy: Timeline Staleness Signal (3/5)
- WT_vDIBH: Results Not Found Signal (2/5)